Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +45

Axon Enterprise, Inc $AXON Shares Sold by Corient Private Wealth LLC

AI-generated analysis

πŸ“‰ Corient Private Wealth LLC reduced its AXON stake by 13.3% to 8,359 shares worth $4.7 million in the fourth quarter.

πŸ“ˆ Sound Income Strategies LLC increased its position by 550%, acquiring an additional 44 shares for a total holding value of $30,000.

πŸ’° Darwin Wealth Management and Creative Financial Designs initiated new positions worth approximately $37,000 and $28,000 respectively.

πŸ“Š Axon reported Q1 revenue of $807.35 million, representing a 33.7% year-over-year increase compared to the prior year.

πŸ’Ή The company beat earnings estimates with $1.61 EPS against a consensus of $1.60 for the quarter.

πŸ“‰ Barclays lowered its price target from $682 to $523 while maintaining an 'overweight' rating on the stock.

🎯 Piper Sandler and Citizens JMP set price targets of $674 and $700 respectively, supporting a consensus target of $712.75.

πŸ’Ό CEO Patrick W. Smith sold 20,000 shares worth $10 million in a pre-arranged Rule 10b5-1 trading plan on June 4th.

πŸ‘©β€πŸ’Ό Executive Elizabeth Reid Coughlin sold 1,554 shares worth approximately $753,690, reducing her direct ownership by 4.37%.

🏦 Insiders collectively sold 38,989 shares worth $19.09 million in the last quarter, though they still own 4.20% of the company.

πŸ›‘οΈ Axon's hardware portfolio includes TASER devices and body-worn cameras paired with a subscription-based digital evidence platform.

πŸ’° The company maintains a healthy balance sheet with a debt-to-equity ratio of 0.49 and a current ratio of 2.27.

Bullish Signals
  • Axon Enterprise reported revenue of $807.35 million for the quarter, beating consensus estimates by $28.45 million and growing 33.7% year-over-year.
  • The company posted earnings per share of $1.61, topping analyst expectations of $1.60, demonstrating consistent profitability.
  • Major analysts including Piper Sandler ($674 target) and Citizens JMP ($700 target) maintain 'overweight' or 'market outperform' ratings with high price targets.
  • The firm maintains a strong liquidity position with a current ratio of 2.27 and a quick ratio of 1.93, indicating robust short-term financial health.
  • Institutional interest remains active with multiple firms like Darwin Wealth Management and Creative Financial Designs initiating new positions in the stock.
Risk Factors
  • CEO Patrick W. Smith sold 20,000 shares worth $10 million in June, signaling a reduction in personal exposure despite the sale being pre-arranged.
  • Analyst Barclays reduced its price target from $682 to $523, indicating some divergence in valuation expectations among major banks.
  • Insiders collectively sold 38,989 shares worth $19.09 million in the last quarter, which may suggest a lack of immediate confidence or liquidity needs.
  • The stock trades at a high PE ratio of 186.79, reflecting significant growth expectations that could be vulnerable to any slowdown in revenue expansion.
Full Analysis
Axon Enterprise, Inc. (NASDAQ: AXON) saw significant institutional activity in the fourth quarter, highlighted by Corient Private Wealth LLC reducing its stake by 13.3% to 8,359 shares. Conversely, several other investors initiated or increased positions, with Sound Income Strategies LLC boosting holdings by 550% and multiple firms like Darwin Wealth Management and Creative Financial Designs acquiring new stakes totaling approximately $100,000 combined. Analyst sentiment remains mixed but generally positive regarding the company's valuation. While Barclays lowered its price target to $523, other major firms like Piper Sandler, Citizens JMP, and Morgan Stanley maintained or set targets between $600 and $700. The consensus rating is a 'Moderate Buy' with an average price target of $712.75, reflecting confidence in the company's growth trajectory despite some profit-taking. Financially, Axon reported strong quarterly results with revenue reaching $807.35 million, a 33.7% year-over-year increase that beat consensus estimates. The company posted earnings per share of $1.61, slightly topping expectations, and maintains a robust balance sheet with a debt-to-equity ratio of 0.49. However, insider selling activity was notable in June, with CEO Patrick W. Smith and executive Elizabeth Reid Coughlin collectively offloading shares worth over $19 million under pre-arranged trading plans. The company continues to dominate the public safety technology sector through its hardware portfolio, including TASER devices and body-worn cameras, paired with a subscription-based digital evidence management platform. With a market capitalization of $37.49 billion and a PE ratio of 186.79, Axon is valued on high growth expectations, supported by revenue expansion but weighed down by recent insider dispositions and varying analyst price targets.